In light of this, and given the complex phenotypic expression of the FMR1 expansions, psychological and neurologic surveillance (in addition to screening for POI in females) may be necessary for relatives of FXS and FXTAS patients, and perhaps for carriers in general. The gene discussed is FMR1; the disease is fragile X-associated tremor/ataxia syndrome.